Immunovant, Inc. (IMVT) vs Spyre Therapeutics, Inc. (SYRE)
Immunovant, Inc. and Spyre Therapeutics, Inc. are both Biotechnology companies. Immunovant, Inc. and Spyre Therapeutics, Inc. are of similar size ($7.7B and $7.1B). Across the 9 metrics below, Spyre Therapeutics, Inc. leads on 8 and Immunovant, Inc. on 1.
Valuation
Profitability
| Metric | IMVT | SYRE | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (80.10%) | (28.52%) | (57.72%) |
| Return on assets | (71.10%) | (20.90%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack